Immediate Impact
33 standout
Citing Papers
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
2024 Standout
Targeting the incretin system in obesity and type 2 diabetes mellitus
2024 Standout
Works of Schafer Boeder being referenced
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
2022
Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Schafer Boeder | 233 | 139 | 130 | 18 | 446 | |
| Anwar A. Jammah | 119 | 56 | 40 | 34 | 424 | |
| Oliver Harzer | 210 | 113 | 71 | 17 | 499 | |
| Israel Tamir | 126 | 111 | 27 | 19 | 474 | |
| Alan W. Patrick | 329 | 176 | 160 | 17 | 452 | |
| Elena Gangitano | 77 | 43 | 41 | 32 | 443 | |
| Jeerunda Santiprabhob | 207 | 103 | 131 | 33 | 377 | |
| João Soares Felício | 202 | 68 | 76 | 35 | 441 | |
| Eka Melson | 168 | 62 | 69 | 34 | 378 | |
| Matthew J. Belanger | 40 | 75 | 34 | 19 | 452 | |
| Haruko Kitaoka | 91 | 69 | 39 | 26 | 431 |
All Works
Login with ORCID to disown or claim papers
Loading papers...